Evidence-Based Oncology
Conference Coverage
Volume: 18
Issue: SP6
December
Volume: 18
Issue: SP5
September
Volume: 18
Issue: SP4
May
Volume: 18
Issue: SP3
February
Volume: 18
Issue: SP1
Advertisement
Advertisement
Trending on AJMC
1
Survodutide Phase 3 Data Signal Metabolic Gains Beyond Weight Loss
2
Measles Cases Climb to 2000 in the US, Increasing Cases Year Over Year
3
Emerging Data Suggest Survodutide Targets Liver Fat More Rapidly Than Weight Loss: Lee Kaplan, MD, PhD
4
Survodutide Normalizes Liver Fat in 61% of Patients With MASLD in Phase 3 Trial: Lee Kaplan, MD, PhD
5